Oragenics (OGEN) Revenue (2010 - 2023)
Oragenics' (OGEN) quarterly Revenue came in at $7466.0 in Q3 2023, down 91.32% on a YoY basis from $86047.0 in Q3 2022, and down 43.28% quarter-over-quarter from $13163.0 in Q2 2023.
Powered by 
Analysis
Oragenics (OGEN) Revenue (2010 - 2023) Analysis & Trends
Oragenics (OGEN) has reported Revenue for 7 consecutive years, with $7466.0 the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Revenue fell 91.32% year-over-year to $7466.0; the trailing twelve-month figure through Dec 2023 stood at $37653.0 (down 71.37% YoY), and the FY2023 full-year result was $37653.0, down 71.37% from the prior year.
- Revenue slipped to $7466.0 in Q3 2023 per OGEN's latest filing, from $13163.0 in the prior quarter.
- Across five years, Revenue topped out at $86047.0 in Q3 2022 and bottomed at $7466.0 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 15.03 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 13.48 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1.67 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 783.30 Mn |
| 10 | Oragenics | 2.35 Mn | 2.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 7,466.00 |
| Jun 30, 2023 | 13,163.00 |
| Mar 31, 2023 | 17,024.00 |
| Sep 30, 2022 | 86,047.00 |
| Jun 30, 2022 | 30,391.00 |
| Mar 31, 2022 | 15,083.00 |
| Dec 31, 2014 | 220,504.00 |
| Sep 30, 2014 | 201,010.00 |
| Jun 30, 2014 | 303,752.00 |
| Mar 31, 2014 | 214,660.00 |
| Dec 31, 2013 | 434,784.00 |
| Sep 30, 2013 | 253,374.00 |
| Jun 30, 2013 | 167,668.00 |
| Mar 31, 2013 | 176,407.00 |
| Dec 31, 2012 | 430,582.00 |
| Sep 30, 2012 | 264,248.00 |
| Jun 30, 2012 | 256,407.00 |
| Mar 31, 2012 | 380,527.00 |
| Dec 31, 2011 | 396,590.00 |
| Sep 30, 2011 | 350,351.00 |